- Home
- SLGL vs UTSI Comparison
SLGL vs UTSI Comparison
Compare SLGL & UTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- UTSI
- Stock Information
- Founded
- SLGL 1997
- UTSI 1991
- Country
- SLGL Israel
- UTSI China
- Employees
- SLGL N/A
- UTSI N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- UTSI Telecommunications Equipment
- Sector
- SLGL Health Care
- UTSI Telecommunications
- Exchange
- SLGL Nasdaq
- UTSI Nasdaq
- Market Cap
- SLGL 19.3M
- UTSI 21.6M
- IPO Year
- SLGL 2018
- UTSI 2000
- Fundamental
- Price
- SLGL $7.26
- UTSI $2.73
- Analyst Decision
- SLGL Buy
- UTSI
- Analyst Count
- SLGL 1
- UTSI 0
- Target Price
- SLGL $40.00
- UTSI N/A
- AVG Volume (30 Days)
- SLGL 25.3K
- UTSI 6.3K
- Earning Date
- SLGL 08-15-2025
- UTSI 07-07-2025
- Dividend Yield
- SLGL N/A
- UTSI N/A
- EPS Growth
- SLGL N/A
- UTSI N/A
- EPS
- SLGL N/A
- UTSI N/A
- Revenue
- SLGL $12,103,000.00
- UTSI $10,878,000.00
- Revenue This Year
- SLGL N/A
- UTSI N/A
- Revenue Next Year
- SLGL $31.17
- UTSI N/A
- P/E Ratio
- SLGL N/A
- UTSI N/A
- Revenue Growth
- SLGL 603.66
- UTSI N/A
- 52 Week Low
- SLGL $3.34
- UTSI $1.84
- 52 Week High
- SLGL $16.50
- UTSI $3.22
- Technical
- Relative Strength Index (RSI)
- SLGL 52.97
- UTSI 54.54
- Support Level
- SLGL $7.02
- UTSI $2.01
- Resistance Level
- SLGL $7.58
- UTSI $2.38
- Average True Range (ATR)
- SLGL 0.37
- UTSI 0.09
- MACD
- SLGL 0.02
- UTSI 0.01
- Stochastic Oscillator
- SLGL 41.28
- UTSI 61.74
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About UTSI UTStarcom Holdings Corp.
UTStarcom Holdings Corp is providing telecommunication network products, solutions and services. It focus on delivering carrier-class packet optical, network synchronization and broadband access (both wireless and fixed line) products and solutions, coupled with Software Defined Networking (SDN) platform, optimized for mobile backhaul, metro aggregation, broadband access and value added services. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. Key revenue is generated from Equipment segment.